OverviewSuggest Edit

Syapse drives healthcare transformation through precision medicine, enabling provider systems to improve clinical outcomes, streamline operations, and shift to new payment models. Syapse Precision Medicine Platform is a comprehensive software suite used by leading health systems to support the clinical implementation of precision medicine in oncology and other service lines. This category-defining platform enables clinical and genomic data integration, decision support, care coordination, and quality improvement at point of care.

TypePrivate
Founded2008
HQSan Francisco, US
Websitesyapse.com
Employee Ratings4.2

Latest Updates

Employees (est.) (Nov 2019)204(+4%)
Job Openings9

Key People/Management at Syapse

Ken Tarkoff

Ken Tarkoff

CEO
Tony Loeser

Tony Loeser

Chief Technology Officer
Dennis Shin

Dennis Shin

Chief Commercial Officer
Andreas Heid

Andreas Heid

Senior Vice President, Customer Operations
James Lim

James Lim

Senior Vice President, Product Development
John Kuelper

John Kuelper

Director, Ascension Ventures
Show more

Syapse Office Locations

Syapse has offices in San Francisco and Philadelphia
San Francisco, US (HQ)
303 2nd St Tower Suite 650, San Francisco
Philadelphia, US
Philadelphia, PA, USA
Show all (2)

Syapse Financials and Metrics

Summary Metrics

Founding Date

2008

Syapse total Funding

$69.6 m

Syapse latest funding size

$30 m

Time since last funding

2 years ago

Syapse investors

Syapse's latest funding round in November 2017 was reported to be $30 m. In total, Syapse has raised $69.6 m
Show all financial metrics

Syapse Online and Social Media Presence

Embed Graph

Syapse News and Updates

FDA partners with Syapse to study regulatory use of real-world evidence

The precision medicine company will work with the U.S. Food and Drug Administration to see how secure patient data can be better put to work in the development of oncology treatments.

South Korea’s SNUH extends partnership with Syapse to expand access to precision medicine

SNUH serves more than 8,000 cancer patients per year across 16 cancer specialty centres, 10 multidisciplinary cancer treatment centres, and a cancer clinical trials centre.

Precision Medicine Leader Syapse to Utilize NCCN Biomarkers Compendium for Clinical Care

PLYMOUTH MEETING, Pa., Nov. 1, 2018 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) today announced a new agreement with Syapse, the leading precision medicine company, to expand the use of best practices in precision medicine when treating people with cancer. Syapse...

Predictive Genetic Testing & Consumer/Wellness Genomics Market Is Expected To Play a Seminal Role in the Ultimate Discovery of Personalized Therapies and Medicines

The offerings of predictive genetic testing and consumer/wellness genomics market is expected to play a seminal role in the ultimate discovery of personalized therapies and medicines. World over, several direct-to-consumer (DTC) genetic testing and healthcare providers offer genetic testing products…

VC-backed Syapse hires oncology VP

San Francisco-based Syapse, a provider of precision medicine solutions, has named Dr. Aradhana Ghosh as vice president of oncology. Ghosh is a former medical oncologist at IBM Watson Health. Syapse's backers include Social Capital, Safeguard Scientifics, Ascension Ventures, GE Ventures, Intermountai…

Syapse Frequently Asked Questions

  • When was Syapse founded?

    Syapse was founded in 2008.

  • Who are Syapse key executives?

    Syapse's key executives are Ken Tarkoff, Tony Loeser and Dennis Shin.

  • How many employees does Syapse have?

    Syapse has 204 employees.

  • Who are Syapse competitors?

    Competitors of Syapse include Flatiron Health, Orion Health and Wellist.

  • Where is Syapse headquarters?

    Syapse headquarters is located at 303 2nd St Tower Suite 650, San Francisco, San Francisco.

  • Where are Syapse offices?

    Syapse has offices in San Francisco and Philadelphia.

  • How many offices does Syapse have?

    Syapse has 2 offices.